Page 28 - Management of Advanced Urothelial Carcinoma: Emerging Therapies and Biomarkers
P. 28

Erdafitinib Dosage and Administration




             Recommended Dosage and Schedule


              •  Recommended starting dose: 8 mg (two 4 mg tablets) orally, once daily, with food

              •  Phosphate intake should be restricted to 600 – 800 mg daily (all patients)
              •  If vomiting occurs, next dose should be taken the next day

              •  Missed dose: take as soon as possible on the same day. Resume regular daily dose schedule the next day
                 (extra tablets should not be taken to make up for the missed dose)

              •  Treatment should continue until disease progression or unacceptable toxicity occurs

             Dose Increase Based on Serum PO Levels
                                                                         4

                Start erdafitinib    Determine serum         •  Increase the dose of erdafitinib to 9 mg once daily if:
                    (8mg)               PO 4 level
                                                                  •  Serum PO level is <5.5 mg/dL
                                                 8 mg                            4
                                                                  •  No ocular disorders or ≥Grade 2 adverse reactions
                                                             •  A dose increase occurred in 41% of patients based on the
                     Day 1               Day     9 mg
                                        14–21                   Day 14 – 21 serum PO level
                                                                                         4


  Janssen Inc. Product Monograph: Balversa. Janssen Canada Inc; 2019
   23   24   25   26   27   28   29   30   31   32   33